<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/">
<channel rdf:about="https://thescipub.com/feed/ajpt/issue-926.rss">
<title>Volume 11, Issue 1 (2016) | American Journal of Pharmacology and Toxicology</title>
<description>Volume 11, Issue 1 (2016) | American Journal of Pharmacology and Toxicology</description>
<link>https://thescipub.com/ajpt/issue/926</link>
<admin:generatorAgent rdf:resource="https://thescipub.com/"/>
<admin:errorReportsTo rdf:resource="mailto:support@thescipub.com"/>
<dc:publisher>Science Publications</dc:publisher>
<dc:language>en</dc:language>
<prism:publicationName>Science Publications</prism:publicationName>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://thescipub.com/ajpt/ajptsp.2016.1.7"/><rdf:li rdf:resource="https://thescipub.com/ajpt/ajptsp.2016.8.19"/></rdf:Seq>
</items>
</channel><item rdf:about="https://thescipub.com/ajpt/ajptsp.2016.1.7">
    <title><![CDATA[Stage Specificity of Eurycomanone Isolated from <i>Eurycoma longifolia</i> on <i>Plasmodium falciparum</i> Cycles]]></title>
    <link>https://thescipub.com/ajpt/ajptsp.2016.1.7</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Pharmacology and Toxicology, Published online: 16 January 2016; <a href="https://thescipub.com/ajpt/ajptsp.2016.1.7">doi:10.3844/ajptsp.2016.1.7</a></p>Eurycomanone is the most active compounds in the roots of Eurycoma longifolia and shown to have in vitro antiplasmodial activity. However, the stage of Plasmodium falciparum cycles which are sensitive...]]></content:encoded>
    <dc:title><![CDATA[Stage Specificity of Eurycomanone Isolated from <i>Eurycoma longifolia</i> on <i>Plasmodium falciparum</i> Cycles]]></dc:title><dc:creator>Eti Nurwening Sholikhah</dc:creator><dc:creator>Mahardika Agus Wijayanti</dc:creator><dc:creator>Ratna Asmah Susidarti</dc:creator><dc:creator>Indah  Purwantini</dc:creator><dc:creator>Rani Afifah Nur Hestiyani</dc:creator><dc:creator>Hanifah  Yusuf</dc:creator><dc:creator>  Mustofa</dc:creator><dc:identifier>doi:10.3844/ajptsp.2016.1.7</dc:identifier>
    <dc:source>American Journal of Pharmacology and Toxicology, Published online: 2016-01-16; | doi:10.3844/ajptsp.2016.1.7</dc:source>
    <dc:date>2016-01-16</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajptsp.2016.1.7</prism:doi>
    <prism:url>https://thescipub.com/ajpt/ajptsp.2016.1.7</prism:url>
    </item><item rdf:about="https://thescipub.com/ajpt/ajptsp.2016.8.19">
    <title><![CDATA[The Duality of AIM2 Inflammasome: A Focus on its Role in Autoimmunity and Skin Diseases]]></title>
    <link>https://thescipub.com/ajpt/ajptsp.2016.8.19</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Pharmacology and Toxicology, Published online: 23 April 2016; <a href="https://thescipub.com/ajpt/ajptsp.2016.8.19">doi:10.3844/ajptsp.2016.8.19</a></p>Understanding the inflammasome biology is one of the most exciting challenges in immuno-pharmacology. The role of the inflammasomes has been recognized in the host defense mechanism against invading p...]]></content:encoded>
    <dc:title><![CDATA[The Duality of AIM2 Inflammasome: A Focus on its Role in Autoimmunity and Skin Diseases]]></dc:title><dc:creator>Miriam  Canavese</dc:creator><dc:identifier>doi:10.3844/ajptsp.2016.8.19</dc:identifier>
    <dc:source>American Journal of Pharmacology and Toxicology, Published online: 2016-04-23; | doi:10.3844/ajptsp.2016.8.19</dc:source>
    <dc:date>2016-04-23</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajptsp.2016.8.19</prism:doi>
    <prism:url>https://thescipub.com/ajpt/ajptsp.2016.8.19</prism:url>
    </item></rdf:RDF>